Nigeria
Industry
BMI View: Ensuring large low-income populations of developing countries have access to primary healthcare services is dependent on two key factors: financial and geographical positioning....
2013-05-02Industry
For Nigerian pharmaceutical firms, obtaining WHO-prequalification status ensures that locally manufactured products gain international acceptance, eliminating the need for donated products....
2013-04-15Industry
BMI View: Boosting bilateral co-operation between Nigerian buyers and Indian drugmakers will directly obstruct the Nigerian government's goal to increase self-sufficiency in medicines...
2013-03-15Industry
BMI View: Nigerian-based Emzor Pharmaceutical Industries is an increasingly strong contender in the local and regional medicines market. With a long-standing key analgesic, Emzor Paracetamol,...
2013-02-28Industry
BMI View: The focus of the Nigerian government's 2013 healthcare budget - increasing wages and pay in order to reduce the 'brain drain' of medical professionals - is understandable....
2013-01-29Industry
BMI View: Chronic medicines uptake and spending on over-the-counter (OTC) medicines in Nigeria will be driven by the government's introduction of universal healthcare coverage, enabling...
2013-01-18Industry
BMI View: Multinationals' presence in emerging markets will continue to be driven by favourable long-term demographic and epidemiological trends. However, we maintain that expansion...
2012-12-10Industry
BMI View: Telemedicine anti-counterfeiting initiatives are largely new in Nigeria, and NAFDAC's latest initiative imposed on local pharmaceutical companies will be welcomed by patients....
2012-10-23
